Viewing Study NCT01980433


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2026-01-24 @ 8:26 PM
Study NCT ID: NCT01980433
Status: COMPLETED
Last Update Posted: 2021-06-15
First Post: 2013-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Inhibitory rTMS in Dystonic Wilson Patients
Sponsor:
Organization:

Raw JSON

{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D006527', 'term': 'Hepatolenticular Degeneration'}, {'id': 'D009069', 'term': 'Movement Disorders'}, {'id': 'D004421', 'term': 'Dystonia'}], 'ancestors': [{'id': 'D008107', 'term': 'Liver Diseases'}, {'id': 'D004066', 'term': 'Digestive System Diseases'}, {'id': 'D001480', 'term': 'Basal Ganglia Diseases'}, {'id': 'D001927', 'term': 'Brain Diseases'}, {'id': 'D002493', 'term': 'Central Nervous System Diseases'}, {'id': 'D009422', 'term': 'Nervous System Diseases'}, {'id': 'D020739', 'term': 'Brain Diseases, Metabolic, Inborn'}, {'id': 'D001928', 'term': 'Brain Diseases, Metabolic'}, {'id': 'D020271', 'term': 'Heredodegenerative Disorders, Nervous System'}, {'id': 'D019636', 'term': 'Neurodegenerative Diseases'}, {'id': 'D030342', 'term': 'Genetic Diseases, Inborn'}, {'id': 'D009358', 'term': 'Congenital, Hereditary, and Neonatal Diseases and Abnormalities'}, {'id': 'D008661', 'term': 'Metabolism, Inborn Errors'}, {'id': 'D008664', 'term': 'Metal Metabolism, Inborn Errors'}, {'id': 'D008659', 'term': 'Metabolic Diseases'}, {'id': 'D009750', 'term': 'Nutritional and Metabolic Diseases'}, {'id': 'D020820', 'term': 'Dyskinesias'}, {'id': 'D009461', 'term': 'Neurologic Manifestations'}, {'id': 'D012816', 'term': 'Signs and Symptoms'}, {'id': 'D013568', 'term': 'Pathological Conditions, Signs and Symptoms'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D050781', 'term': 'Transcranial Magnetic Stimulation'}, {'id': 'D007854', 'term': 'Lead'}], 'ancestors': [{'id': 'D055909', 'term': 'Magnetic Field Therapy'}, {'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D019216', 'term': 'Metals, Heavy'}, {'id': 'D004602', 'term': 'Elements'}, {'id': 'D007287', 'term': 'Inorganic Chemicals'}, {'id': 'D008670', 'term': 'Metals'}]}}, 'protocolSection': {'designModule': {'phases': ['NA'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'CROSSOVER'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 14}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2014-01', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2021-06', 'completionDateStruct': {'date': '2015-07', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2021-06-14', 'studyFirstSubmitDate': '2013-10-24', 'studyFirstSubmitQcDate': '2013-11-04', 'lastUpdatePostDateStruct': {'date': '2021-06-15', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2013-11-11', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2015-07', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'immediate and significant improvement in writing', 'timeFrame': 'up to 1 week', 'description': 'Improvement of handwriting performance immediately after one single 20 minutes session of inhibitory (1 Hz) repetitive transcranial magnetic stimulation over the left somatosensory cortex.\n\nquantitative test score of writing WCRS\n\nActive or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.'}], 'secondaryOutcomes': [{'measure': 'significant improvement in writing', 'timeFrame': 'up to 1 week', 'description': 'improvement of other quantitative test scores of writing (VAS subjective discomfort writing, DPRE scales and parameters measured on touchpad) after a single session of 1 Hz rTMS inhibitory to the left CSS , compared to the scores achieved in the 24 hours before the session of rTMS.\n\nActive or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.'}, {'measure': 'improvement of dystonia on the scale WDRS', 'timeFrame': 'up to 1 week', 'description': 'Assessing the improvement of dystonia on the scale WDRS after a single session of 1 Hz rTMS inhibitory to the left CSS, compared to the scores achieved in the 24 hours before the session of rTMS.\n\nActive or sham stimulation will be randomly assigned to the patient and the other session will be performed 3 days later.'}, {'measure': 'correlation between the scores and the other parameters of disease severity', 'timeFrame': 'up to 1 week', 'description': 'Assess whether age, disease duration and the presence of cortical atrophy are inversely correlated with the evolution of scores.'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Wilson disease', 'Dystonia', 'Movement Disorders', 'Handwriting', 'Repetitive Transcranial Magnetic Stimulation'], 'conditions': ['Wilson Disease', 'Movement Disorders', 'Repetitive Transcranial Magnetic Stimulation']}, 'descriptionModule': {'briefSummary': 'Wilson disease is a genetic disorder resulting in copper accumulation in liver, brain and eye. The neurologic complications include dystonic syndrome, which is a prolonged and excessive muscle activation responsible for abnormal postures. Hand dystonia prevents daily life activities such as writing, which is particularly disabling, since writing is the only mean of communication in these patients with significant slurred speech. Treatment is limited and only partially effective.\n\nLow frequency (\\<or=1Hz) repetitive transcranial magnetic stimulation (rTMS) has shown inhibiting properties when applied over the cortex. Since dystonia has been correlated to hyperactivation of the neurons of the somatosensory cortex (SSC), we hypothesize that one single 20-minute session of 1 Hz rTMS applied on left SSC will improve writing of the right dystonic hand, assessed immediately at the end of the session.', 'detailedDescription': 'This study investigates the handwriting performance of an homogeneous cohort of patients with Wilson disease and right handed dystonia, after one single inhibitory repetitive transcranial magnetic stimulation (rTMS). Fifteen patients with focal right hand dystonia will receive randomly either active or sham rTMS (1 Hz) to the left somatosensory cortex (SSC) in one single 20 minutes session. Handwriting performance will be measured immediately after this unique session (Visual analogic scale of subjective discomfort in writing, DPRE and WCRS scales, pen pressure and pen velocity measured on touchpad), compared to scores obtained 24 hours before the session. Three days later, the patient will receive the other session (sham rTMS or active rTMS) and the same parameters will be evaluated.\n\nThis is a single-center, randomized, crossover, prospective, clinical and double-blind study (the rTMS session is performed by the neurophysiologist, but the patient and the neurologist who will perform the handwriting evaluation are blind to the session).'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Wilson disease with focal right hand dystonia\n* No modification of medical treatment for 6 months\n* No botulinum toxin administration within the past four months\n* Right handed\n* Focal right hand dystonia\n* Cerebral Magnetic Resonance performed the last 6 months with no other lesion than met in Wilson disease\n* Over 18\n* Insurance policy holder\n* Informed consent\n\nExclusion Criteria:\n\n* Pregnant woman\n* Guardianship procedure\n* Seizure history\n* Other cerebral lesions on cerebral MRI than met in Wilson Disease\n* Unable to stay quiet for 30 minutes\n* Handwriting impossible\n* Contra-indications to repetitive Transcranial Magnetic Stimulation'}, 'identificationModule': {'nctId': 'NCT01980433', 'acronym': 'WILSTIM', 'briefTitle': 'Inhibitory rTMS in Dystonic Wilson Patients', 'organization': {'class': 'OTHER', 'fullName': 'Assistance Publique - Hôpitaux de Paris'}, 'officialTitle': 'Study of Writing Improvement in Patients With Wilson Disease and Dystonia After One Session of Inhibitory Repetitive Transcranial Magnetic Stimulation', 'orgStudyIdInfo': {'id': 'P121105'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Active rTMS', 'description': 'Repetitive Transcranial Magnetic stimulation: 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.', 'interventionNames': ['Device: Repetitive Transcranial Magnetic Stimulation (rTMS)', 'Other: pre and post-rTMS electroencephalogram', 'Other: WCRS', 'Other: handwriting scale DPRE', 'Other: visual analog scale of discomfort writing and parameters collected on touchpad']}, {'type': 'SHAM_COMPARATOR', 'label': 'Sham rTMS', 'description': 'Placebo Transcranial Magnetic stimulation delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.', 'interventionNames': ['Device: Repetitive Transcranial Magnetic Stimulation (rTMS)', 'Other: pre and post-rTMS electroencephalogram', 'Other: WCRS', 'Other: handwriting scale DPRE', 'Other: visual analog scale of discomfort writing and parameters collected on touchpad']}], 'interventions': [{'name': 'Repetitive Transcranial Magnetic Stimulation (rTMS)', 'type': 'DEVICE', 'description': 'Inhibitory 1 Hz rTMS, delivered to left somatosensory cortex during rest. Intervention is delivered during 20 minutes in one single session.', 'armGroupLabels': ['Active rTMS', 'Sham rTMS']}, {'name': 'pre and post-rTMS electroencephalogram', 'type': 'OTHER', 'description': 'to verify the absence of infraclinical seizures', 'armGroupLabels': ['Active rTMS', 'Sham rTMS']}, {'name': 'WCRS', 'type': 'OTHER', 'description': "Writer's cramp rating scale", 'armGroupLabels': ['Active rTMS', 'Sham rTMS']}, {'name': 'handwriting scale DPRE', 'type': 'OTHER', 'description': 'handwriting in development and being evaluated by the NRC Wilson', 'armGroupLabels': ['Active rTMS', 'Sham rTMS']}, {'name': 'visual analog scale of discomfort writing and parameters collected on touchpad', 'type': 'OTHER', 'armGroupLabels': ['Active rTMS', 'Sham rTMS']}]}, 'contactsLocationsModule': {'locations': [{'zip': '75010', 'city': 'Paris', 'state': 'Île-de-France Region', 'country': 'France', 'facility': 'Hospital Lariboisiere', 'geoPoint': {'lat': 48.85341, 'lon': 2.3488}}], 'overallOfficials': [{'name': 'Nathalie KUBIS, MD, PhD', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Physiology Department, Lariboisière Hospital'}, {'name': 'Jean-Marc TROCELLO, MD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Neurology, Lariboisière Hospital'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Assistance Publique - Hôpitaux de Paris', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}